Experimental group:Pyrotinib

3 trials

Sponsors

The Third Hospital of Nanchang, The fist hospital of china medical university, Beijing Tiantan Hospital, Capital Medical University

Conditions

Breast cancersolid tumors

Phase 4

Real-world study for pyrotinib in the treatment of HER2-positive advanced breast cancer

Active, not recruitingChiCTR1900023152

The Third Hospital of NanchangBreast cancer

Start: 2019-06-01Updated: 2019-05-20

A real-world study of pyrotinib maleate in the treatment of brain metastases from HER2-positive solid tumors

Active, not recruitingChiCTR2200058265

Beijing Tiantan Hospital, Capital Medical Universitysolid tumors

Start: 2022-03-31Updated: 2023-12-19

Unknown Phase

Neoadjuvant pyrotinib in patients with HER2-positive breast cancer:a multicentre, retrospective real-world study

Active, not recruitingChiCTR2100048895

The fist hospital of china medical universityBreast cancer

Start: 2021-07-19Updated: 2022-03-28